Showing results (1-10 of 186) with videos related to
Sort By:
Pageof 19
Handbook of Experimental Pharmacology|August 12, 2020
NOX Inhibitors: From Bench to Naxibs to BedsideMahmoud H Elbatreek, Hermann Mucke, Harald H H W SchmidtArchives of Pharmacal Research|September 4, 2009
Emerging role of nitrite in myocardial protectionDavid J LeferBiomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 8, 2022
Current advances on the therapeutic potential of pinocembrin: An updated reviewMahmoud H Elbatreek, Ismail Mahdi, Wafae Ouchari, et al.European Journal of Pharmacology|August 11, 2025
Agomelatine and Empagliflozin Synergistically Protect Against Diabetic Cardiomyopathy via Nrf2/HO-1 SignalingNada A Elbaik, Shimaa M Elshazly, Atef El-Gharbawy, et al.Pharmaceuticals (Basel, Switzerland)|October 27, 2022
<i>Agathis robusta</i> Bark Extract Protects from Renal Ischemia-Reperfusion Injury: Phytochemical, <i>In Silico</i> and <i>In Vivo</i> StudiesMaged E Mohamed, Nora Tawfeek, Samar S Elbaramawi, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 29, 2025
Synergistic alleviation of obesity and associated cardiovascular complications by combined modulation of FASN/Arginase/eNOS uncouplingEbtesam Ahmed Sabry, Mahmoud H Elbatreek, Hany M El-Basossy, et al.Biochimica Et Biophysica Acta|October 12, 2007
Sphingolipid therapy in myocardial ischemia-reperfusion injurySusheel Gundewar, David J LeferAmerican Heart Journal|July 2, 2005
Cardioprotection before revascularization in ischemic myocardial injury and the potential role of hemoglobin-based oxygen carriersDaniel Burkhoff, David J LeferJournal of Cardiovascular Pharmacology and Therapeutics|August 9, 2011
Development of an NIH consortium for preclinicAl AssESsment of CARdioprotective therapies (CAESAR): a paradigm shift in studies of infarct size limitationDavid J Lefer, Roberto BolliPageof 19